Home
Technology
Orynotides
Therapeutics
Inflammatory Disease
Infectious Disease
Pipeline
About us
Company
Management Team
Scientific Advisory Board
Board of Directors
News
Publications
Contact
Home
Technology
Orynotides
Therapeutics
Inflammatory Disease
Infectious Disease
Pipeline
About us
Company
Management Team
Scientific Advisory Board
Board of Directors
News
Publications
Contact
Dalton Announces a Drug Development and GMP Manufacturing Services Agreement with Oryn Therapeutics
By
Richard
April 12, 2018
Uncategorized
No Comments
0
0
0
http://www.prweb.com/releases/2018/03/prweb15308936.htm
Leave a Reply
Cancel Reply
Name
*
Email
*
Website
Recent Posts
Oryn Awarded Four Year Grant by NIH for Cyclic Orynotides for Systemic MDR Candidiasis
May 29, 2020
Oryn and University of Southern California Scientists Report Significant Advance in Antifungal Drug Therapy
December 4, 2019
Dalton Announces a Drug Development and GMP Manufacturing Services Agreement with Oryn Therapeutics
April 12, 2018
USC Press release: Oryn and University of Southern California scientists report on first-in-class macrocyclic peptide therapeutic for treatment of rheumatoid arthritis
November 30, 2017
PLoS ONE publication: Oryn and USC collaborators publish in PLoS ONE the application of Orynotides for treatment of evolving and severe rheumatoid arthritis
November 29, 2017
Oryn selected to present at 2016 BIO International Convention
June 7, 2016
Oryn Therapeutics and Keck Medicine of USC RECEIVE $5.3 M NIH award
May 17, 2016
Oryn therapeutics secures $3,000,000 of angel investment
September 2, 2015
